Grants for For profit organizations other than small businesses - Science and Technology

The Kalamazoo Community Foundation (KZCF) is offering the Women’s Education Coalition Grant Program, designed to support women in pursuing educational and employment goals. This program aligns with the foundation's mission to foster increased financial independence and career advancement within the community. By providing renewable grant assistance, KZCF aims to break down financial barriers that often hinder women from accessing further education or professional development, thereby promoting economic mobility and overall community well-being. The Women's Education Coalition is a collaborative effort involving Alpha Kappa Alpha Sorority, Inc.; Delta Sigma Theta Sorority, Inc.; the YWCA of Kalamazoo; and the former Kalamazoo Network, highlighting a collective commitment to empowering women through education. The target beneficiaries for this grant program are women residing in Kalamazoo, Barry, Calhoun, Allegan, St. Joseph, or Van Buren County who have experienced a significant break in their education or are seeking additional education to improve their career and pay opportunities. The primary impact goal is to enhance the financial independence of these women and facilitate their career progression. The grant can be utilized for various educational pathways, including professional development, trade, technology, vocational or certificate programs, as well as associate's, bachelor's, or master's degree programs, accommodating both part-time and full-time students. The program prioritizes underemployed working mothers and those enrolling or already enrolled in not-for-profit educational institutions. This focus underscores KZCF's strategic emphasis on supporting vulnerable populations and promoting access to education within the non-profit sector, which often serves a broader community benefit. Applicants are required to demonstrate how post-high school education will contribute to their goals of increased financial independence, ensuring that the grant's impact is directly linked to tangible personal and economic improvements. Expected outcomes include a measurable increase in the financial independence and career opportunities for grant recipients. While specific measurable results are not explicitly detailed in the provided information, the program's design suggests that success would be evaluated by the number of women who successfully complete their chosen educational programs, secure better employment, or achieve higher income levels as a direct result of the grant. The foundation's theory of change appears to center on the belief that targeted financial assistance for education directly leads to improved economic stability and empowerment for individuals, which in turn contributes to a more vibrant and equitable community.

Grant Opportunity: U.S. & Chinese Foreign Policy and Relations Research Grants Funder: The Charles Koch Foundation Award Details: Funding levels are commensurate with the requirements of the research and the potential for the research to advance an understanding of critical issues. Accepted proposals may also receive support to disseminate the research findings. Eligibility: Organizations of all types across the USA, including nonprofits, startups, researchers, local governments, and small businesses. Other Relevant Information: - Proposals should focus on analyzing China's future prospects, examining challenges in leveraging economic clout in foreign policy, exploring avenues for productive engagement with China, studying potential causes of conflict in East Asia and strategies for mitigation, evaluating different U.S. military postures in East Asia, assessing the balance of power between China and other countries in Asia, considering implications of emergent technologies for U.S. security interests in East Asia, studying power transition literature, exploring behavior of East Asian states towards balancing or bandwagoning with China, examining issues related to U.S.-China trade and foreign direct investment, and evaluating the real threat posed by China compared to claimed threats. - Application requirements include a two-to-five page abstract, a CV or résumé, and a brief itemized budget. - Proposals will be accepted and evaluated on a rolling basis. - The Charles Koch Foundation aims to remove barriers that prevent people from reaching their potential by supporting research and innovations in postsecondary education. For more information and to apply for this grant opportunity, visit https://charleskochfoundation.tfaforms.net/344037?tfa_13=tfa_1475

This program provides funding to Indiana's local governments to assist low-income homeowners with essential repairs that improve safety, comfort, and accessibility in their residences.

This funding opportunity provides financial support for research and development projects focused on improving battery technologies, particularly for electric vehicles, and is open to a wide range of applicants including educational institutions, nonprofits, and government entities.

The Women’s Foundation of Arkansas (WFA) is launching its fifth Women’s Economic Mobility Hub (WEM Hub) cohort, a program specifically designed to support Black women-owned businesses. This initiative aligns directly with the WFA's mission to advance economic mobility for women, particularly focusing on a demographic that often faces significant barriers to business growth. By providing a comprehensive suite of resources, the WEM Hub seeks to address systemic inequities and foster sustainable economic empowerment. The primary target beneficiaries of the WEM Hub program are existing businesses that are at least 75% owned and operated by one or more Black women who are U.S. citizens. These businesses must be physically located and operating for over one year within Arkansas, and be in good standing with the Arkansas Secretary of State and current on all taxes. The program specifically excludes not-for-profit entities, focusing instead on for-profit corporations, partnerships, LLPs, LLCs, or sole proprietorships. The core impact goal is to scale these Black women-owned businesses through robust support and unrestricted grant funding. The WEM Hub program prioritizes technical assistance, offering a six-month intensive program that combines online training and in-person meetings. Key areas of focus include expert advice on accounting, financial management, business development, and legal services. Participants also receive ongoing mentorship, engage in peer-to-peer learning sessions, and gain training in communications, public relations, marketing, and leadership skill development. A significant component is the opportunity to establish relationships with participating financial institutions, which is crucial for long-term growth and stability. Expected outcomes include enhanced business acumen, improved financial literacy, and stronger market presence for participating businesses. The program aims for measurable results through the provision of $5,000 in unrestricted grant funds to each business, directly contributing to their scaling efforts. The WFA's strategic priority is to create a tangible pathway for Black women entrepreneurs to not only survive but thrive, thereby reducing economic disparities and contributing to the overall economic health of Arkansas. The underlying theory of change is that by equipping Black women business owners with tailored support, financial resources, and networking opportunities, their businesses will experience accelerated growth, leading to increased economic mobility and wealth creation for the entrepreneurs and their communities.

To implement a project aimed at advancing U.S. foreign policy and national security priorities outlined in the Creating Helpful Incentives to Produce Semiconductors (CHIPS) Act of 2022 (Div. A, P.L. 117-167). The Act established a new International Technology Security and Innovation Fund (ITSI Fund) to to support the development and adoption of secure semiconductors, [and] semiconductor supply chains with the goal to make the global semiconductor supply chain more resilient, diversified, and secure.

Orthopaedic injuries have a profound impact on military readiness and return to work/activity/duty. In the military, extremity battle wounds comprise approximately 50% of injuries reported in the Department of Defense Trauma Registry. Additionally, orthopaedic injuries and conditions that occur outside of combat (e.g., during training, leisure activities, resultant from old injuries, etc.) present one of the greatest threats to the readiness of our Service Members and military. Early stabilization, treatment, and rehabilitation of orthopaedic injuries in both civilian and military populations have led to better outcomes, particularly in the prevention of secondary complications and in minimizing morbidity. Availability of orthopaedic care and treatment as early as possible, or as close to the point of injury as possible, also minimizes limb loss and affects military readiness.Although the PRORP is interested in supporting military-focused research, research supported by the PRORP is expected to also apply to all individuals who have sustained a major orthopaedic injury.With the initiation of the Arthritis Research Program, the FY24 PRORP may not fund arthritis research; however, research that addresses conditions or health abnormalities related to arthritis is permitted provided the proposed research addresses the selected Focus Area.The FY24 PRORP ARA seeks applied research applications focused on advancing optimal treatment and restoration of function for individuals with orthopaedic injuries sustained during combat and service-related activities. Applicants are encouraged to address how the proposed research will support patient care and allow patients to more quickly return to duty/work. It is expected that any research findings would also provide benefit to the general population. To meet the intent of the award mechanism, applications must specifically address an FY24 PRORP ARA Focus Area, listed in Section II.A.1, above.The FY24 PRORP ARA is focused on applied research, defined as work that refines concepts and ideas into potential solutions with a view toward evaluating technical feasibility of promising new knowledge products, pharmacologic agents, behavioral and rehabilitation interventions, diagnostic and therapeutic techniques, clinical guidance, and/or emerging approaches and technologies.Awards may not be used to support fundamental basic research. Basic research is defined as research directed toward greater knowledge or understanding of the fundamental aspects of phenomena and of observable facts without specific applications toward process or products in mind.Research Scope: Research proposed under the FY24 PRORP ARA may include small- to large-scale projects. Upon successful completion, the proposed research is expected to yield knowledge products, approaches, or technologies that have the potential to advance toward clinical translation. Strong transition plans are expected.Inclusion of preliminary and/or published data relevant to the proposed research is required. Applicants must demonstrate logical reasoning for the proposed work. To be competitive, the application must include a sound scientific rationale and a well-formulated, testable hypothesis established through a critical review and analysis of the literature.Studies allowed under the FY24 PRORP ARA may include, but are not limited to: Refinement of concepts and ideas into potential solutions, or research tools, with a view toward evaluating technical feasibility of emerging approaches, technologies, and promising new knowledge products. Evaluation, maturation, and/or down-selection of potential product candidates (drugs, biologic constructs, or devices/systems) in vitro and/or in vivo. Preparation activities needed to support a future clinical trial or regulatory submission.Applications to the FY24 PRORP ARA mechanism must support preclinical applied research and may not be used for clinical research studies. Applicants seeking support for clinical research projects should consider the FY24 PRORP Clinical Translational Research Award (Funding Opportunity Number HT942524PRORPCTRA), Clinical Trial Award (Funding Opportunity Number HT942524PRORPCTA), or Womens Health Research Award (Funding Opportunity Number HT942524PRORPWHRA) mechanisms.The funding instrument for awards made under the program announcement will be grants (31 USC 6304).Rigor of Experimental Design: All projects should adhere to a core set of standards for rigorous study design and reporting to maximize the reproducibility and translational potential of preclinical research. The standards are described in SC Landis et al., 2012, A call for transparent reporting to optimize the predictive value of preclinical research, Nature 490:187-191 (www.nature.com/nature/journal/v490/n7419/full/nature11556.html). While these standards are written for preclinical studies, the basic principles of randomization, blinding, sample-size estimation, and data handling derive from well-established best practices in clinical studies. Projects that include research on animal models are required to submit Attachment 8, Animal Research Plan, as part of the application package to describe how these standards will be addressed. Applicants should consult the ARRIVE guidelines 2.0 (Animal Research: Reporting In Vivo Experiments) to ensure relevant aspects of rigorous animal research are adequately planned for and, ultimately, reported. The ARRIVE guidelines 2.0 can be found at https://arriveguidelines.org/arrive-guidelines.Womens Health Research: The CDMRP encourages research on health areas and conditions that affect women uniquely, disproportionately, or differently from men, including studies analyzing sex as a biological variable. Such research should relate anticipated project findings to improvements in women's health outcomes and/or advancing knowledge for women's health. Applications proposing research that solely address womens health may also consider the FY24 PRORP WHRA mechanism, Funding Opportunity Number HT942524PRORPWHRA.Encouraged Department of Defense (DOD) and/or VA Collaboration: Military relevance is a key feature of this award. Principal Investigators (PIs) are encouraged, but not required, to collaborate with DOD or VA researchers and clinicians.Use of DOD or VA Resources: If the proposed research involves access to DOD or VA resources or databases, the application must describe the access at the time of submission and include a plan for maintaining access as needed throughout the proposed research. Refer to Section II.D.2.b.ii, Full Application Submission Components, for detailed information. Refer to the General Application Instructions, Appendix 1, for additional information.The anticipated total costs budgeted for the entire period of performance for an FY24 PRORP Applied Research Award should not exceed $750,000. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.Awards supported with FY24 funds will be made no later than September 30, 2025.The CDMRP expects to allot approximately $3.75M to fund approximately five ARA applications. Funding of applications received is contingent upon the availability of federal funds for this program, the number of applications received, the quality and merit of the applications as evaluated by peer and programmatic review, and the requirements of the government. Funds to be obligated on any award resulting from this funding opportunity will be available for use for a limited time period based on the fiscal year of the funds. It is anticipated that awards made from this FY24 funding opportunity will be funded with FY24 funds, which will expire for use on September 30, 2030.

This grant provides funding for researchers and organizations to explore and develop innovative scientific projects related to space and Earth sciences, with a focus on emerging worlds and planetary exploration.

This funding opportunity supports nonprofit organizations, educational institutions, and government agencies in Hawaiʻi to develop projects that boost the local film and creative industries, fostering economic growth and community benefits.

This funding opportunity provides financial support to local governments in Illinois for rehabilitating homes occupied by low-to-moderate income households, promoting neighborhood revitalization and improving housing conditions.

The City of Rockford’s Business Growth Program offers forgivable loans to for-profit businesses to advance business operations. The program's core mission aligns with fostering business development and growth, specifically targeting job creation for low-to-moderate income individuals. While not explicitly a "foundation," the city acts as the funding entity with a clear strategic priority: local economic development through business support and employment opportunities for specific demographics. The program serves as a tangible mechanism to implement this theory of change by providing financial incentives for growth that directly contribute to job creation. The primary target beneficiaries are for-profit businesses legally established and operating within the City of Rockford’s municipal boundaries, specifically those in commercially or industrially zoned properties, and established by May 1, 2024. A key focus is on businesses located in eligible census tracts, ensuring that the benefits of the program are directed towards areas identified as needing economic upliftment. The impact goal is to stimulate business expansion, leading to increased employment opportunities for low-to-moderate income individuals within the city. The program prioritizes projects that involve the purchase of equipment and operating expenses associated with business expansion. This includes inventory, employee salaries, rent, and advertising/marketing expenses. These priorities directly support businesses in their growth phases, addressing common financial hurdles they may face when expanding operations. By focusing on these areas, the program aims to maximize the potential for businesses to scale up and, consequently, create more jobs. Expected outcomes include a tangible increase in business development and job creation for low-to-moderate income individuals. While specific measurable results are not explicitly detailed beyond "up to $25,000 in gap funding" and "job creation," the implied metrics would be the number of businesses supported, the total value of loans disbursed, and the number of new jobs created for the target demographic. The city's strategic priority is to strengthen its local economy and reduce unemployment among its low-to-moderate income residents, with this program acting as a direct tool to achieve those measurable results.

Proposers must retrieve the instructions document (zip file) associated with the application package for this opportunity as there is at least one required form that must be attached to the submitted proposal package. The National Aeronautics and Space Administration (NASA) Science Mission Directorate (SMD) released its annual omnibus Research Announcement (NRA), Research Opportunities in Space and Earth Sciences (ROSES) 2024 (OMB Approval Number 2700-0092, CFDA Number 43.001) on February 14, 2024. In this case "omnibus" means that this NRA has many individual program elements, each with its own due dates and topics. All together these cover the wide range of basic and applied supporting research and technology in space and Earth sciences supported by SMD. Awards will be made as grants, cooperative agreements, contracts, and inter- or intra-agency transfers, depending on the nature of the work proposed, the proposing organization, and/or program requirements. However, most extramural research awards deriving from ROSES will be grants, and many program elements of ROSES specifically exclude contracts, because contracts would not be appropriate for the nature of the work solicited. The typical period of performance for an award is three years, but some programs may allow up to five years and others specify shorter periods. In most cases, organizations of every type, Government and private, for profit and not-for-profit, domestic and foreign (with some caveats), may submit proposals without restriction on teaming arrangements. Tables listing the program elements and due dates (Tables 2 and 3), a table that provides a very top level summary of proposal contents (Table 1), and the full text of the ROSES-2024 "Summary of Solicitation", may all be found NSPIRES at http://solicitation.nasaprs.com/ROSES2024. This synopsis is associated with one of the individual program elements within ROSES, but this is a generic summary that is posted for all ROSES elements. For specific information on this particular program element download and read the PDF of the text of this program element by going to Tables 2 or 3 of this NRA at http://solicitation.nasaprs.com/ROSES2024table2 and http://solicitation.nasaprs.com/ROSES2024table3, respectively, click the title of the program element of interest, a hypertext link will take you to a page for that particular program element. On that page, on the right side under "Announcement Documents" the link on the bottom will be to the PDF of the text of the call for proposals. For example, if one were interested in The Lunar Data Analysis Program (NNH24ZDA001N-LDAP) one would follow the link to the NSPIRES page for that program element and then to read the text of the call one would click on C.8 Lunar Data Analysis Program (.pdf) to download the text of the call. If one wanted to set it into the context of the goals, objectives and know the default rules for all elements within Appendix C, the planetary science division, one might download and read C.1 Planetary Science Research Program Overview (.pdf) from that same page. While the letters and numbers are different for each element within ROSES (A.12, B.7, etc.) the basic configuration is always the same, e.g., the letter indicates the Science Division (A is Earth Science, B is Heliophysics etc.) and whatever the letter, #1 is always the division overview. Frequently asked questions for ROSES are posted at http://science.nasa.gov/researchers/sara/faqs. Questions concerning general ROSES-2024 policies and procedures may be directed to Max Bernstein, Lead for Research, Science Mission Directorate, at [email protected], but technical questions concerning specific program elements should be directed to the point(s) of contact for that particular element, who may be found either at the end of the individual program element in the summary table of key information or on the web list of topics and points of contact at: http://science.nasa.gov/researchers/sara/program-officers-list. Not all program elements are known at the time of the release of ROSES. To be informed of new program elements or amendments to this NRA, proposers may subscribe to: (1) The SMD mailing lists (by logging in at http://nspires.nasaprs.com and checking the appropriate boxes under "Account Management" and "Email Subscriptions"), (2) The ROSES-2024 blog feed for amendments, clarifications, and corrections to at https://science.nasa.gov/researchers/solicitations/roses-2024/, and (3) The ROSES-2024 due date Google calendars (one for each science division). Instructions are at https://science.nasa.gov/researchers/sara/library-and-useful-links (link from the words due date calendar).

The Somerset County Tourism Grant Program, funded by GO Laurel Highlands, offers grants ranging from $10,000 to $100,000 to nonprofit or for-profit businesses in the tourism and hospitality industry in Somerset County, Pennsylvania, for marketing initiatives and visitor center operations aimed at boosting tourism and overnight stays in the region.

Orthopaedic injuries have a profound impact on military readiness and return to work/activity/duty. In the military, extremity battle wounds comprise approximately 50% of injuries reported in the Department of Defense Trauma Registry. Additionally, orthopaedic injuries and conditions that occur outside of combat (e.g., during training, leisure activities, resultant from old injuries) present one of the greatest threats to the readiness of our Service Members and military. Early stabilization, treatment, and rehabilitation of orthopaedic injuries in both civilian and military populations have led to better outcomes, particularly in the prevention of secondary complications and in minimizing morbidity. Availability of orthopaedic care and treatment as early as possible, or as close to the point of injury as possible, also minimizes limb loss and affects military readiness.Although the PRORP is interested in supporting military-focused research, research supported by the PRORP is expected to also apply to all individuals who have sustained a major orthopaedic injury.With the initiation of the Arthritis Research Program, the FY24 PRORP may not fund arthritis research; however, research that addresses conditions or health abnormalities related to arthritis is permitted provided the proposed research addresses the selected Focus Area.The PRORP CTRA is intended to support high-impact and/or emerging clinical research that may not be ready for a full-scale randomized controlled clinical trial. Projects should demonstrate potential to impact the standard of care, both immediate and long-term, as well as contribute to evidence-based guidelines for the evaluation and care of military, Veterans, and all patients with orthopaedic injuries. One goal of the FY24 PRORP CTRA is to translate current and emerging techniques and interventions into the clinical space to better serve military and non-military patients. A holistic approach that takes into account the health, functional abilities, and quality of life of individuals who have sustained an orthopaedic injury should be considered. Another goal is to identify the most effective diagnosis, treatment, rehabilitation, and prevention options available to support critical decision-making for patients, clinicians, other caregivers, and policymakers.The FY24 PRORP CTRA differs from the FY24 PRORP Clinical Trial Award (CTA) in that the CTRA allows for clinical research projects that may or may not include a clinical trial, whereas the CTA is restricted to clinical trials only.Funding from this award mechanism must support clinical research and may not be used for animal research.Clinical research encompasses research with patient samples, data, and interaction with patients that may or may not be considered a clinical trial. Clinical research is observational in nature and includes: (1) Research that does not seek to evaluate the effects of interventions. Research conducted with human subjects (or on material of human origin such as data, tissues, specimens, and cognitive phenomena) for which an investigator (or colleague) directly interacts with human subjects but does not seek to assess the effects of an intervention, qualifies as clinical research. Patient-oriented research may include but is not limited to: (a) mechanisms of human disease, (b) diagnostic or detection studies (e.g., biomarker or imaging), (c) health disparity studies, and (d) development of new technologies. (2) Epidemiologic and behavioral studies that do not seek to study the safety, effectiveness, and/or efficacy outcomes of an intervention. (3) Outcomes research and health services research that do not fit under the definition of clinical trial. Excluded from the definition of clinical research are in vitro studies that utilize human tissues that cannot be linked to a living individual. Note: Studies that meet the requirements for exemption under 46.104(d)(4) of the Common Rule are not considered clinical research as defined by the CDMRP. Exemption category 4 refers to secondary research for which consent is not required.A clinical trial is defined in the Code of Federal Regulations, Title 45, Part 46.102 (45 CFR 46.102) as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include a placebo or another control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes.Studies that do not seek to measure safety, effectiveness, and/or efficacy outcome(s) of an intervention are not considered clinical trials.For more information, a Human Subject Resource Document is provided at https://cdmrp.health.mil/pubs/pdf/Human%20Subjects%20Resource%20Document_DEC2022.pdf.Proposed studies submitted to the CTRA may be interventional and may involve some retrospective data analysis. Note that purely retrospective or database-related research is not allowed under this funding opportunity. Small pilot clinical trials with human subjects are allowable.Key aspects of the PRORP CTRA mechanism: Preliminary Data Are Required: Inclusion of preliminary data relevant to the proposed clinical research is required. Study Population: The application should demonstrate the availability of and access to a suitable patient population that will support a meaningful outcome for the study. The application should include a discussion of how accrual goals will be achieved, as well as the strategy for inclusion of women and minorities in the clinical research appropriate to the objectives of the study. Studies utilizing human biospecimens or datasets that cannot be linked to a specific individual, gender, ethnicity, or race (typically classified as exempt from Institutional Review Board [IRB] review) are exempt from this requirement. Intervention Availability: The application should demonstrate the documented availability of and access to the drug/compound, device, and/or other materials needed, as appropriate, for the proposed duration of the study. Statistical Analysis and Data Management Plans: The application should include a clearly articulated statistical analysis plan, a power analysis reflecting sample size projections that will answer the objectives of the study, and a data management plan that includes use of an appropriate database to safeguard and maintain the integrity of the data. If proposing a clinical trial that requires oversight by a Regulatory Agency, the trial must use a 21 CFR 11-compliant database and appropriate data standards.For the purposes of this funding opportunity, Regulatory Agency refers to the U.S. Food and Drug Administration (FDA) or any relevant international regulatory agency unless otherwise noted.If the proposed clinical research involves the use of a drug that has not been approved by the relevant Regulatory Agency for the country where the research will be conducted, then submission of an Investigational New Drug (IND) application, or equivalent, that meets all requirements under 21 CFR 312 may be required. It is the responsibility of the applicant to provide evidence from the IRB of record or the relevant Regulatory Agency if an IND, or equivalent, is not required. If an IND, or equivalent, is required, the regulatory application must be submitted to the relevant Regulatory Agency within 12 months of the CTRA award start date. The IND, or equivalent, should be specific for the product and indication to be tested in the proposed clinical trial. For more information on IND applications specifically, the FDA has provided guidance at https://www.fda.gov/drugs/types-applications/investigational-new-drug-ind-application.If the investigational product is a device, then submission of an Investigational Device Exemption (IDE), or equivalent, application that meets all requirements under 21 CFR 812 may be required. It is the responsibility of the applicant to provide evidence if an IDE, or equivalent, is not required. If an IDE, or equivalent, is required, the IDE application, or equivalent, must be submitted to the relevant Regulatory Agency within 12 months of the CTRA award start date. The IDE, or equivalent, should be specific for the device and indication to be tested in the proposed clinical trial.Womens Health: The CDMRP encourages research on health areas and conditions that affect women uniquely, disproportionately, or differently from men, including studies analyzing sex as a biological variable. Such research should relate anticipated project findings to improvements in women's health outcomes and/or advancing knowledge for women's health. Applications proposing research that solely address womens health may also consider the FY24 PRORP WHRA mechanism, Funding Opportunity Number HT942524PRORPWHRA.Use of Department of Defense (DOD) or VA Resources: If the proposed research involves access to DOD or VA resources or databases, the application must describe the access at the time of submission and include a plan for maintaining access as needed throughout the proposed research. Refer to Section II.D.2.b.ii, Full Application Submission Components, for detailed information.The funding instrument for awards made under the program announcement will be grants (31 USC 6304).The anticipated total costs budgeted for the entire period of performance for an FY24 PRORP CTRA should not exceed $1.5M. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.Awards supported with FY24 funds will be made no later than September 30, 2025.The CDMRP expects to allot approximately $6.0M to fund approximately four CTRA applications. Funding of applications received is contingent upon the availability of federal funds for this program, the number of applications received, the quality and merit of the applications as evaluated by peer and programmatic review, and the requirements of the government. Funds to be obligated on any award resulting from this funding opportunity will be available for use for a limited time period based on the fiscal year of the funds. It is anticipated that awards made from this FY24 funding opportunity will be funded with FY24 funds, which will expire for use on September 30, 2030.

Grant Opportunity: Health Care Research Grants Funder: The Charles Koch Foundation Award Details: The Charles Koch Foundation is inviting scholars, researchers, and subject matter experts to submit grant proposals for research, case studies, or comparative analysis on barriers to better health care and how to address them. The foundation is particularly interested in topics such as innovative payment systems, the role of markets in health care delivery and payment systems, public policy affecting health care demand and financing, impediments to disruptive provider models and technologies, and historical analysis of the U.S. health care system. Funding levels will be determined based on the research requirements and potential impact. Eligibility: Organizations of all types across the USA are eligible to apply for these grants. This includes nonprofits, startups, researchers, local governments, small businesses, and other organizations interested in conducting research related to improving health care. Other Relevant Information: Applicants are required to submit a one-to-two-page abstract of their project along with a CV or résumé and a brief itemized budget. Final projects should be original and meet high standards in their field. Accepted proposals may also receive support for disseminating research findings. Proposals will be accepted on a rolling basis. For more information about this grant opportunity and to apply, please visit the Charles Koch Foundation's website at https://charleskochfoundation.tfaforms.net/344037?tfa_13=tfa_1473

The United Way of the Wabash Valley is offering Successful Parenting Initiative Grants of $1,000 to $10,000 for projects that enhance parental knowledge of early childhood development and improve parenting practices, with a focus on early detection of developmental delays and increasing school readiness in children, open to nonprofits, for-profits, local government units, and faith-based and community organizations in specified counties of Indiana and Illinois.

This funding opportunity provides financial support to organizations working to strengthen export controls and compliance measures against the Chinese Communist Party's efforts to acquire advanced technologies for military and economic purposes.

This funding opportunity provides financial support for research consortia focused on improving the diagnosis and treatment of rare diseases through collaborative, patient-centered clinical studies involving multiple institutions and patient advocacy groups.

The Business Development Grant Program, offered by the Town of Perryville, Maryland, is designed to stimulate economic development within the town's corporate limits. Its primary objectives are to foster new job opportunities, reduce the number of vacant storefronts, encourage business diversification, attract additional private sector investment, and promote in-fill business development. This program aligns with a strategic goal of local government to create a vibrant and sustainable economic environment, though specific "foundation mission alignment" beyond this general goal is not explicitly stated as this is a municipal program rather than a private foundation. The target beneficiaries of this program are new and existing small businesses located within the Town of Perryville. The program aims to support these businesses by providing funds necessary for operational needs, thereby ensuring their financial viability and encouraging growth. The ultimate impact goals include strengthening the local economy, increasing employment, and enhancing the overall business landscape of Perryville. The emphasis on filling vacant storefronts and encouraging diversification suggests a focus on revitalizing commercial areas and expanding the range of goods and services available to residents and visitors. The program prioritizes a broad range of eligible uses for funds, including building improvements, the purchase of machinery, equipment, furniture, fixtures, inventory, property acquisition or leasing, and advertising campaigns. This comprehensive approach reflects a strategic priority to support various aspects of business development and expansion. The eligibility criteria further refine the program's focus, requiring applicants to be in good standing with the Town, Cecil County, and the State of Maryland, and to operate within specific zoning districts (Neighborhood Business, Town Center, Highway Commercial, Residential Marine, Commercial Maritime, and for existing businesses, Residential districts). This indicates a deliberate strategy to concentrate development in designated commercial and mixed-use areas. Expected outcomes and measurable results include an increase in new job creation, a reduction in the number of unoccupied commercial properties, a more diverse local business sector, and a rise in private sector investment. While specific metrics are not detailed in the provided information, the program's objectives inherently suggest these as key performance indicators. The "theory of change" underpinning this grant is that by providing financial assistance for operational needs and growth initiatives, the Town of Perryville can directly stimulate business activity, which in turn will lead to economic growth and community benefits. This proactive approach by the municipality serves as its strategic priority for economic development.

This grant provides funding for innovative cancer research projects that address the unique health needs of military personnel, veterans, and their families, focusing on specific cancer types and strategic goals related to prevention, diagnosis, treatment, and survivorship.